Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7HOFFMANN LA ROCHE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 8470818

Drug Substance Claim :

Drug Product Claim :

Application Number : 202429

Patent Use Code : U-2164

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-02

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 8470818

Drug Substance Claim :

Drug Product Claim :

Application Number : 202429

Patent Use Code : U-1418

Delist Requested :

Patent Use Description : TREATMENT OF PATIENTS ...

Patent Expiration Date : 2026-08-02

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 8143271

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202429

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-06-21

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 9447089

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 202429

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-06-06

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 7863288

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202429

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-20

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 8741920

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202429

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-27

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

VEMURAFENIB

US Patent Number : 7504509

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202429

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-10-22

blank